© 2018 by Chimeric Designs Inc. USA

  • Facebook Social Icon
  • Twitter Social Icon
  • LinkedIn Social Icon

We are a protein engineering company, developing the world’s first multifunctional antibody-drug conjugate (ADC), to make chemotherapy more efficient.


Current cancer treatments can be ineffective and cause debilitating side effects. 

Chimeric Designs is developing multifunctional and targeted therapeutics to improve the health and well-being of patients with cancer. 

13% of non-Hodgkin’s Lymphoma cancer patients die from the direct effects of chemotherapy in the first 30 days of treatment. Chimeric Designs is working towards making chemotherapy treatment work more efficiently.